😰Fear Articles

AI news with negative sentiment and concerning developments

Showing articles for 2026-01-13, 2026-01-14
Ars Technica😰 Fear

Google removes some AI health summaries after investigation finds “dangerous” flaws

AI Overviews provided false liver test information experts called alarming.

Ars Technica😰 Fear

UK probes X over Grok CSAM scandal; Elon Musk cries censorship

Grok tests if UK can penalize platforms for sexualized deepfakes generated by AI.

AI News😰 Fear

Allister Frost: Tackling workforce anxiety for AI integration success

Navigating workforce anxiety remains a primary challenge for leaders as AI integration defines modern enterprise success. For enterprise leaders, deploying AI is less a technical hurdle than a complex

AI News😰 Fear

The latency trap: Smart warehouses abandon cloud for edge

While the enterprise world rushes to migrate everything to the cloud, the warehouse floor is moving in the opposite direction. This article explores why the future of automation relies on edge AI to s

AI News😰 Fear

The Meta-Manus review: What enterprise AI buyers need to know about cross-border compliance risk

Meta’s US$2 billion acquisition of AI agent startup Manus has become every enterprise CTO’s cross-border compliance risk lesson. China’s Ministry of Commerce announced on January 9 that it would asses

The Verge😰 Fear

Bandcamp becomes the first major music platform to ban AI content

Bandcamp has built its entire brand around serving artists. And, with the artist furor over AI growing every day, it's no surprise that the company has decided to take a stand against it. In a Reddit

Ars Technica😰 Fear

Deny, deny, admit: UK police used Copilot AI “hallucination” when banning football fans

Police finally come clean about botched use of AI tools.

Ars Technica😰 Fear

Microsoft vows to cover full power costs for energy-hungry AI data centers

Company responds to community concerns over electricity bills and water use.

AI News😰 Fear

AstraZeneca bets on in-house AI to speed up oncology research

Drug development is producing more data than ever, and large pharmaceutical companies like AstraZeneca are turning to AI to make sense of it. The challenge is no longer whether AI can help, but how ti